Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05675332 · ClinicalTrials.gov registry record · NA
Effects of Stereotype Threat on Impulsivity and Its Relation to Alcohol Use in African Americans: An fMRI Study
A NA study of Alcohol Drinking, sponsored by Icahn School of Medicine at Mount Sinai.
- Recruiting
- Registry status
- NA
- Development phase
- 280
- Enrollment target
- 1
- Study location
NCT05675332: Recruiting NA study of Alcohol Drinking, sponsored by Icahn School of Medicine at Mount Sinai.
NCT05675332 is a NA study of Alcohol Drinking that is actively recruiting participants, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 280 participants, below the 627-participant average among 85 other Alcohol Drinking trials with a reported enrollment target (55% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05675332, a NA study of Alcohol Drinking, is actively recruiting participants, sponsored by Icahn School of Medicine at Mount Sinai.
- RECRUITING
- Registry status
- NA
- Development phase
- 280 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to investigate the behavioral and neural correlates of stress exposure. Results from this study will enrich the understanding of how sociocultural, behavioral, and neural factors combine to influence alcohol use.
Primary Outcome
Blood oxygen-level dependent (BOLD) signal in brain regions of interest (ROI) measured using fMRI
Conditions Studied
Interventions
- BEHAVIORAL Task-based behavioral intervention
Study Locations (1)
New York
- Icahn School of Medicine at Mount Sinai - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 280 participants |
| Start Date | 2022-12-09 |
| Est. Completion | 2026-01-31 |
| Phase | NA |
What NCT05675332 shows while recruiting
NCT05675332 is an interventional study that assigns participants to a tested intervention. The registered 280 participants enrollment target is mid-sized for trials with a published cap, below the 627-participant average among 85 other Alcohol Drinking trials with a reported enrollment target (55% lower).
The record links to 1 condition, with Alcohol Drinking appearing as the primary indexed condition, and to 1 intervention - of which Task-based behavioral intervention is the first listed.
NCT05675332 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT05675332 about?
NCT05675332 is a clinical study titled "Effects of Stereotype Threat on Impulsivity and Its Relation to Alcohol Use in African Americans: An fMRI Study". The purpose of this study is to investigate the behavioral and neural correlates of stress exposure. Results from this study will enrich the understanding of how sociocultural, behavioral, and neural factors combine to influence alcohol use.
What is the current status of trial NCT05675332?
This trial is currently recruiting. It is a NA study. The enrollment target is 280 participants. The study started on 2022-12-09. Estimated completion is 2026-01-31.
What conditions does trial NCT05675332 study?
This clinical trial studies the following conditions: Alcohol Drinking.
What interventions are being tested in trial NCT05675332?
The interventions under investigation include: Task-based behavioral intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT05675332?
This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05675332 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Alcohol Drinking
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05675332's enrollment target sits among peer trials
280 35th of 85 higher than 51 of 85 other Alcohol Drinking trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Alcohol Drinking trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Alcohol and "Heat of the Moment" Sexual Decision Making
RECRUITING · NA
-
Acceptance and Commitment Therapy for HIV+ Hazardous Drinkers
RECRUITING · NA
-
The GLUCID Study: Effect of Alcohol Reduction and Probiotic Interventions on Cognition and Brain Glucose Metabolism in Normal Aging Adults Who Are High-Risk Alcohol Drinkers
RECRUITING · NA
-
Multi-Component Breath Alcohol Intervention Phase 3
RECRUITING · NA
-
Mobile Intervention for Simultaneous Alcohol and Marijuana Use in Young Adults
RECRUITING · NA
-
A SMART Evaluation of an Adaptive Web-based AUD Treatment for Service Members and Their Partners
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04084730 · 280 participants · Phase 2
Study of 3-Day Partial Breast Radiation Therapy in Women With Breast Cancer
- NCT04518657 · 280 participants · NA
Internet-Delivered Lifestyle Physical Activity Intervention for Cognitive Processing Speed in Multiple Sclerosis
- NCT04634916 · 280 participants · NA
Post-market Surveillance Study of the BD® WavelinQ™ EndoAVF System
- NCT04829617 · 280 participants · NA
Promoting Well-being and Health in Heart Failure
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI